INNOVATE Corp
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(18) Basic and Diluted Earnings (Loss Per Common Share
- Basic and Diluted Earnings (Loss) Per Common Share
Earnings (loss) per share ("EPS") is calculated using the two-class method, which allocates earnings among common stock and participating securities to calculate EPS when an entity's capital structure includes either two or more classes of common stock or common stock and participating securities. Unvested share-based payment awards and Series C Preferred Stock that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities. As such, shares of any unvested restricted stock and Series C Preferred Stock of the Company are considered participating securities; however, unvested restricted stock do not participate in losses and, as such, are excluded from the computation of basic earnings (loss) per share during periods of net losses. The dilutive effect, if applicable, of stock options and their equivalents (including non-vested stock issued under stock-based compensation plans), is computed using the "if-converted method" if this measurement is determined to be more dilutive than the treasury stock method in a period.
The Company hadno dilutive common stock equivalents during the six months ended June 30, 2024 and the three and six months ended June 30, 2023, due to the results from continuing operations being a loss, net of tax. For the three months ended June 30, 2024, all stock options were excluded from the weighted average number of shares used to calculate diluted loss per share as their inclusion would have been anti-dilutive. For the six months ended June 30, 2024,912,955 of common stock equivalents from unvested restricted stock were excluded from the weighted average number of shares used to calculate diluted loss per share as their inclusion would have been anti-dilutive. Other instruments that may, in the future, if the average market price of the Company's stock exceeds the conversion prices, have a dilutive effect on earnings per share, but were excluded from the computation of diluted net loss per share for the six months ended June 30, 2024 and for three and six months ended 2023 are: preferred stock, convertible debt and stock options. Refer to Note 14. Share-based Compensation and Note 15. Equity and Temporary Equity for additional information on INNOVATE's equity instruments.
The following table presents a reconciliation of net income (loss) used in the basic and diluted EPS calculations (in millions, except shares and per share amounts):
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net income (loss) | $13.9 | $(11.7) | $(6.2) | $(19.7) |
| Net loss attributable to non-controlling interest and redeemable non-controlling interest | 0.5 | 1.8 | 3.2 | 0.8 |
| Net income (loss) attributable to INNOVATE Corp. | 14.4 | (9.9) | (3.0) | (18.9) |
| Less: Preferred dividends | 0.3 | 0.6 | 0.6 | 1.8 |
| Net income (loss) attributable to common stockholders and participating preferred stockholders | $14.1 | $(10.5) | $(3.6) | $(20.7) |
| Earnings (loss) allocable to common shares: | ||||
| Participating shares at end of period: | ||||
| Weighted average common shares outstanding | 89,204,850 | 77,922,241 | 83,929,228 | 77,806,010 |
| Unvested restricted stock | 1,122,921 | — | — | — |
| Series C Preferred stock | 36,530,623 | — | 19,050,241 | — |
| Total | 126,858,394 | 77,922,241 | 102,979,469 | 77,806,010 |
| Percentage of earnings (loss) allocated to: | ||||
| Common stock | 70.3% | 100.0% | 81.5% | 100.0% |
| Unvested restricted stock | 0.9% | —% | —% | —% |
| Series C Preferred stock | 28.8% | —% | 18.5% | —% |
| Numerator for earnings (loss) per share | ||||
| Net income (loss) attributable to common stock holders, basic | $9.9 | $(10.5) | $(2.9) | $(20.7) |
| Effect of assumed shares under the if-converted method for preferred stock, convertible instruments and unvested restricted stock | 4.9 | — | — | — |
| Net income (loss) attributable to common stock holders, diluted | $14.8 | $(10.5) | $(2.9) | $(20.7) |
| Denominator for earnings (loss) per share: | ||||
| Weighted average common shares outstanding - basic | 89,204,850 | 77,922,241 | 83,929,228 | 77,806,010 |
| Effect of assumed shares under the if-converted method for preferred stock, convertible instruments and participating unvested restricted stock | 55,052,702 | — | — | — |
| Weighted average common shares outstanding - diluted | 144,257,552 | 77,922,241 | 83,929,228 | 77,806,010 |
| Earnings (loss) per share | ||||
| Basic | $0.11 | $(0.13) | $(0.03) | $(0.27) |
| Diluted | $0.10 | $(0.13) | $(0.03) | $(0.27) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.